Lymphoma Clinical Trials in San Antonio

Showing 441-444 of 444 trials

Chemotherapy for Patients With Advanced Solid Tumors or Non-Hodgkin's Lymphoma

NCT00090727

The purposes of this study are to determine: * the largest dose of AQ4N that can be safely given once a week for three weeks out of a 4 week cycle * the side effects of AQ4N when given on the above schedule * how much AQ4N is in the blood and urine at specific times after administration and how the body get rids of AQ4N * if AQ4N helps treat cancer

Solid MalignanciesNon-Hodgkin's Lymphoma

Novacea45 participantsStarted Aug 2004

The Bronx, New York, United States • San Antonio, Texas, United States

COMPLETEDPhase 2130 miles

Proleukin in Combination With Rituxan in Patients With Intermediate and High-Grade Non-Hodgkin's Lymphoma.

NCT00045864

The purpose of this study is to determine the safety and effectiveness of combination therapy with Proleukin and Rituxan on patients with intermediate-and high- grade Non-Hodgkin's lymphoma.

Lymphoma, Non-Hodgkin

Chiron Corporation

Tucson, Arizona, United States • Newport Beach, California, United States • Sacramento, California, United States +30 more locations

Chemotherapy for Patients With Advanced Solid Tumors or Non-Hodgkin's Lymphoma

Proleukin in Combination With Rituxan in Patients With Intermediate and High-Grade Non-Hodgkin's Lymphoma.

Lymphoma Trials in Other Cities

Study to Evaluate MEDI-507 in Patients With CD2-Positive Lymphoma/Leukemia

Safety and Efficacy of (PN-152,243)/PN-196,444 in the Prevention of Thrombocytopenia

Other Conditions in San Antonio